EXANE DERIVATIVES - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$452,000
-2.4%
140.0%0.00%
Q1 2022$463,000
-22.3%
140.0%0.00%
Q4 2021$596,000
-3.9%
140.0%0.00%
Q3 2021$620,000
-97.0%
14
-96.4%
0.00%
-100.0%
Q2 2021$20,459,000
-29.9%
3900.0%0.01%
-37.5%
Q1 2021$29,190,000
-13.5%
3900.0%0.01%
-20.0%
Q4 2020$33,737,000
+9092.6%
390
+6400.0%
0.01%
Q3 2020$367,000
+47.4%
60.0%0.00%
Q2 2020$249,000
+44.8%
60.0%0.00%
Q1 2020$172,000
-61.7%
60.0%0.00%
Q4 2019$449,000
-46.7%
60.0%0.00%
Q3 2019$842,000
-23.3%
60.0%0.00%
Q2 2019$1,098,000
+15.1%
60.0%0.00%
Q1 2019$954,000
+65.9%
60.0%0.00%
Q4 2018$575,000
-31.1%
60.0%0.00%
Q3 2018$834,000
-99.2%
6
-99.1%
0.00%
-100.0%
Q2 2018$103,215,000
-0.1%
6620.0%0.02%
-19.0%
Q1 2018$103,305,0006620.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders